BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Song L, Yang F, Wang Z, Yang L, Zhou Y. Ginsenoside Rg5 inhibits cancer cell migration by inhibiting the nuclear factor-κB and erythropoietin-producing hepatocellular receptor A2 signaling pathways. Oncol Lett 2021;21:452. [PMID: 33907562 DOI: 10.3892/ol.2021.12713] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
Number Citing Articles
1 Heo H, Kim Y, Cha B, Brito S, Kim H, Kim H, Fatombi BM, Jung SY, Lee SM, Lei L, Lee SH, Park G, Kwak B, Bin B, Park J, Lee M. A systematic exploration of ginsenoside Rg5 reveals anti-inflammatory functions in airway mucosa cells. Journal of Ginseng Research 2022. [DOI: 10.1016/j.jgr.2022.06.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Hou Z, Song F, Xing J, Zheng Z, Liu S, Liu Z. Comprehensive fecal metabolomics and gut microbiota for the evaluation of the mechanism of Panax Ginseng in the treatment of Qi-deficiency liver cancer. J Ethnopharmacol 2022;292:115222. [PMID: 35341933 DOI: 10.1016/j.jep.2022.115222] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wang H, Zheng Y, Sun Q, Zhang Z, Zhao M, Peng C, Shi S. Ginsenosides emerging as both bifunctional drugs and nanocarriers for enhanced antitumor therapies. J Nanobiotechnology 2021;19:322. [PMID: 34654430 DOI: 10.1186/s12951-021-01062-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
4 Panossian A, Abdelfatah S, Efferth T. Network Pharmacology of Red Ginseng (Part I): Effects of Ginsenoside Rg5 at Physiological and Sub-Physiological Concentrations. Pharmaceuticals (Basel) 2021;14:999. [PMID: 34681222 DOI: 10.3390/ph14100999] [Cited by in F6Publishing: 2] [Reference Citation Analysis]